+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cell cycle proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia



Cell cycle proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia



Journal of Pathology 181(Suppl. ): 21A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030436632

Download citation: RISBibTeXText


Related references

Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. Journal of Pathology 184(4): 396-400, 1998

Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. Journal of Pathology 198(4): 458-467, 2002

Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ. Archives of Pathology and Laboratory Medicine 140(7): 686-689, 2017

Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management. Molecular Medicine Reports 2(6): 923-929, 2009

Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia: An immunohistochemical study. Pathology International 50(7): 527-530, 2000

Expression of cyclins in ductal hyperplasia, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Yonsei Medical Journal 41(3): 345-353, 2000

Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy. Applied Spectroscopy 71(2): 300-307, 2018

Cyclin D1 expression in usual hyperplasia, atypical ductal hyperplasia and low nuclear grade ductal carcinoma in situ of the breast An immunohistochemical study. Journal of Pathology 187(Suppl. ): 25A, 1999

Clinical, radiographic, and pathologic correlation of atypical hyperplasia, ductal carcinoma in situ, and ductal carcinoma in situ with micro-invasion. Breast 2(1): 21-26, 1993

Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation. Virchows Archiv 439(1): 70-77, 2001

Comparison of rate limiting factors in the transformation of atypical ductal hyperplasia and ductal carcinoma in situ of the breast using immunohistochemistry and fluorescence in situ hybridization. Modern Pathology 16(1): 50A, 2003

Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion. Human Pathology 32(8): 785-790, 2001

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Breast Cancer Research and Treatment 41(2): 103-109, 1996

CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia. Breast Cancer Research and Treatment 84(3): 247-250, 2004

Ductal carcinoma in situ and bilateral atypical ductal hyperplasia in a 23-year-old man with gynecomastia. American Surgeon 77(9): 1272-1273, 2011